Search

Your search keyword '"Arzoomanian RZ"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Arzoomanian RZ" Remove constraint Author: "Arzoomanian RZ"
22 results on '"Arzoomanian RZ"'

Search Results

1. A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days.

2. Gemcitabine, Paclitaxel, and piritrexim: a phase I study.

3. Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors.

4. Phase I study of eniluracil, oral 5-fluororacil and gemcitabine in patients with advanced malignancy.

5. Phase I and pharmacokinetic study of a micronized formulation of carboxyamidotriazole, a calcium signal transduction inhibitor: toxicity, bioavailability and the effect of food.

6. Clinical conduct and nursing quality of life in prostate cancer.

7. Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day.

8. Phase I trial of intravenous thymidine and carboplatin in patients with advanced cancer.

9. A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia.

10. Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812).

11. Phase I clinical trial of perillyl alcohol administered daily.

12. Phase I clinical and pharmacokinetic trial of penclomedine using a novel, two-stage trial design for patients with advanced malignancy.

13. A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumors.

14. Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalan.

15. Phase I clinical and pharmacokinetic study of oral carboxyamidotriazole, a signal transduction inhibitor.

16. Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients.

17. Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study.

18. Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.

19. Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients.

20. A phase I trial of 5-fluorouracil, leucovorin, and dipyridamole given by concurrent 120-h continuous infusions.

21. Phase I clinical trial of fazarabine as a twenty-four-hour continuous infusion.

22. A phase I study of SR-2508 and cyclophosphamide administered by intravenous injection.

Catalog

Books, media, physical & digital resources